GRI Bio, Inc. (GRI) stock
GRINasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.35−0.05 (-3.54%)
Close on Nov 17, 2026Market cap $2.95MP/E –Yield –
GRI Bio operating margin
Operating margin is operating income as a percentage of revenue.
GRI Bio's operating margin for the twelve months ending Dec 31, 2020 was -4788.0%. For fiscal 2020 it was -4788.0%.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | -4788.0% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2020 | Mar 31, 2020 | -1158.0% | – |
See a number that looks wrong?